Conduit Pharmaceuticals Files 8-K on Security Holder Rights
Ticker: CDTTW · Form: 8-K · Filed: May 16, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, legal-changes
TL;DR
Conduit Pharma (CPHI) filed an 8-K detailing changes to security holder rights and corporate bylaws, effective May 15th.
AI Summary
Conduit Pharmaceuticals Inc. filed an 8-K on May 16, 2025, reporting material modifications to security holder rights and amendments to its articles of incorporation or bylaws, effective May 15, 2025. The filing also includes Regulation FD disclosures and financial statements/exhibits. Conduit Pharmaceuticals Inc. was formerly known as Murphy Canyon Acquisition Corp. and changed its name on November 30, 2021.
Why It Matters
This 8-K filing indicates significant changes to Conduit Pharmaceuticals' corporate structure or security holder agreements, which could impact investors' rights and the company's governance.
Risk Assessment
Risk Level: medium — Filings detailing modifications to security holder rights and corporate bylaws can introduce new risks or alter existing ones for investors.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- May 15, 2025 (date) — Effective date of reported events
- May 16, 2025 (date) — Filing date of the 8-K
- Murphy Canyon Acquisition Corp. (company) — Former company name
- November 30, 2021 (date) — Date of name change
FAQ
What specific material modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the excerpt. Further review of the full filing is required.
What amendments were made to Conduit Pharmaceuticals Inc.'s articles of incorporation or bylaws?
The filing states that amendments were made to the articles of incorporation or bylaws, but the specific nature of these amendments is not detailed in the provided text. The full document would contain these details.
When did the reported events become effective?
The reported events became effective on May 15, 2025.
What was Conduit Pharmaceuticals Inc. formerly known as?
Conduit Pharmaceuticals Inc. was formerly known as Murphy Canyon Acquisition Corp.
When did the company change its name?
The company changed its name on November 30, 2021.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).